Represented a U.S. venture capital fund in a $4.5M Series A lead investment in an Israeli healthcare technology company.
Represented an Israeli industrial company known as a world leader in pipe fittings in a $140 million sale to a NYSE-listed US company specializing in the manufacturing and marketing of products for municipal water systems.
Represented a privately held healthcare management and solutions company in a $3.5 million secured convertible note financing transaction, the proceeds from which will be used to open and expand company-managed health clinics and for other general corporate purposes.
Represented a US-based materials technology company in connection with the company’s approximately $27 million sale of stock to a Japanese manufacturing company.
Represented a custom software design company with operations in U.S. and Israel in connection with a strategic buyer’s acquisition of substantially all of the assets and liabilities of the company.
Represented the sole shareholder of a web hosting company in connection with the company’s approximately $16 million sale to a public hosting and distribution company.
Represented Electro-Science Laboratories, Inc. in its acquisition by Ferro Corporation, also involving the concurrent acquisition of Agmet Limited in the UK and the assets of their sister corporation in Shanghai, China.
Advised Venture Fundusz Inwestycyjny Zamknięty, managed by TFI Trigon S.A., in connection with the acquisition of a non-controlling stake in Seed Labs Inc., a U.S.-based corporation involved in the development of an end-to-end smart lighting platform using new transmission protocols.
Represented Amazon Ventures in a Series D investment in WhoSay, Inc.
Represented Consol Energy, Inc. in a $3.5 billion sale of Consolidation Coal Company to a subsidiary of Murray Energy Corporation.
Represented publicly traded Finnish manufacturing company in its acquisition of a division of a large U.S. company, including the purchase of stock and assets of subsidiaries located in the United States and five foreign countries, and the coordination of closings in different countries across different calendar years.
Represented multinational publicly traded Swedish manufacturing company in its acquisition of a division of a Fortune 500 company, including the purchase of stock and assets of subsidiaries located in 12 different countries.
Represented multinational publicly traded Indian company in the acquisition of a California corporation.
Represented Nasdaq-traded CRO in the acquisition of a Finnish corporation for a combination of cash and stock. The transaction involved complex cross-border securities issues.
Represented Israel-based provider of application problem resolution software in its acquisition by a large U.S. software company, structuring and negotiating a complex stock purchase agreement that incorporated the use of a novel statutory "take along" provision.
Represented Israel-based leading manufacturer of armored equipment in its acquisition of a Michigan-based defense contractor
Represented Mid-Atlantic late-stage venture fund in an investment in a rapidly expanding provider of medical market research.
Represented US-based biotech company in a Series B round investment that was leady by a Swiss based, global life science fund and a leading California-based life sciences investment firm.
Represented US-based corporation engaged in the development of alternative energy sources in a significant investment by a leading Israeli private equity fund.
Represented Israeli-based biotech company in a worldwide license and distribution agreement with a leading Italian pharma company.
Represented a technology company that specializes in automated quality management systems in connection with its $2.5 million Series A offering.